Announcements Trials

Browse Landscape

Phase

Phase 3 3 Phase 2 3 Phase 1/2 1

Sponsor

Interventions

pembrolizumab 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Radiotherapy 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 sugemalimab 1 semaglutide 1 sacituzumab govitecan 1 prednylidene 1 pirtobrutinib 1 paricalcitol 1 mirdametinib 1 gadobutrol 1 fludarabine phosphate 1 fludarabine 1 erdafitinib 1 enfortumab vedotin 1 deltacortene 1 daratumumab 1 brivaracetam 1 brexucabtagene autoleucel 1 azeliragon 1 avelumab 1 alovudine 1 acalabrutinib 1 Watchful Waiting 1 Vorinostat 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Ogivri × 30 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡